Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin
- 30 November 1990
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Hepatology
- Vol. 11 (3), 349-353
- https://doi.org/10.1016/0168-8278(90)90220-l
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A 5-year experience of lipiodolization: Selective regional chemotherapy for 200 patients with hepatocellular carcinomaHepatology, 1989
- Effects of transcatheter arterial chemoembolization with oral chemotherapy on hepatic neoplasmasCancer Chemotherapy and Pharmacology, 1989
- Selective effect of doxorubicin suspended in lipiodol on VX2 carcinoma in rabbitsJournal of Surgical Oncology, 1988
- Hepatocellular carcinoma. A retrospective analysis of treatments to manage disease confined to the liverCancer, 1988
- Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast mediumCancer, 1984
- Primary liver cancer. An eastern cooperative oncology group trialCancer, 1984
- Prognosis of Primary Hepatocellular CarcinomaHepatology, 1984
- Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary reportEuropean Journal of Cancer and Clinical Oncology, 1983
- INDUCTION OF REMISSION IN HEPATOCELLULAR CARCINOMA WITH DOXORUBICINThe Lancet, 1978
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958